Pancreatic cancer | Control group 1 (screened negative) | Control group 2 (chronic pancreatitis) | Control group 3 (acute pancreatitis) | Control groups 1 + 2 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | 95 | 27 | 97 | 59 | 124 | ||||||
Mean age (years) (range) | 66 | 45–85 | 60 | 37–82 | 57 | 22–87 | 56 | 22–87 | 58 | 22–87 | |
Sex (% men) | 57 | 60 | 12 | 44.44 | 67 | 69.07 | 32 | 54.24 | 79 | 63.71 | |
Smoking status | Currently (%) | 30 | 31.58 | 11 | 40.74 | 64 | 65.98 | 23 | 38.98 | 75 | 60.48 |
Previously (%) | 33 | 34.74 | 7 | 25.93 | 24 | 24.74 | 11 | 18.64 | 31 | 25.00 | |
Never (%) | 30 | 31.58 | 9 | 33.33 | 9 | 9.28 | 23 | 38.98 | 18 | 14.52 | |
Unknown status (%) | 2 | 2.11 | 0 | 0 | 0 | 0 | 2 | 3.39 | 0 | 0 | |
AJCC/UICC staging | I (IA and IB) (%) | 11 | 11.58 | ||||||||
II (IIA and IIB) (%) | 29 | 30.53 | |||||||||
III (%) | 13 | 13.68 | |||||||||
IV (%) | 42 | 44.21 |